A detailed history of Morse Asset Management, Inc transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Morse Asset Management, Inc holds 5,241 shares of TMDX stock, worth $317,237. This represents 0.19% of its overall portfolio holdings.

Number of Shares
5,241
Previous 5,341 1.87%
Holding current value
$317,237
Previous $839,000 2.03%
% of portfolio
0.19%
Previous 0.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

SELL
$135.68 - $176.11 $13,568 - $17,611
-100 Reduced 1.87%
5,241 $822,000
Q3 2024

Nov 14, 2024

BUY
$135.68 - $176.11 $724,666 - $940,603
5,341 New
5,341 $839,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $1.93B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Morse Asset Management, Inc Portfolio

Follow Morse Asset Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morse Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Morse Asset Management, Inc with notifications on news.